Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1709804rdf:typepubmed:Citationlld:pubmed
pubmed-article:1709804lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:1709804lifeskim:mentionsumls-concept:C0040053lld:lifeskim
pubmed-article:1709804lifeskim:mentionsumls-concept:C0040034lld:lifeskim
pubmed-article:1709804lifeskim:mentionsumls-concept:C0019134lld:lifeskim
pubmed-article:1709804lifeskim:mentionsumls-concept:C0019142lld:lifeskim
pubmed-article:1709804lifeskim:mentionsumls-concept:C0184661lld:lifeskim
pubmed-article:1709804lifeskim:mentionsumls-concept:C0026385lld:lifeskim
pubmed-article:1709804lifeskim:mentionsumls-concept:C0205251lld:lifeskim
pubmed-article:1709804lifeskim:mentionsumls-concept:C1524063lld:lifeskim
pubmed-article:1709804lifeskim:mentionsumls-concept:C0442087lld:lifeskim
pubmed-article:1709804lifeskim:mentionsumls-concept:C0851827lld:lifeskim
pubmed-article:1709804lifeskim:mentionsumls-concept:C1701901lld:lifeskim
pubmed-article:1709804lifeskim:mentionsumls-concept:C0069610lld:lifeskim
pubmed-article:1709804pubmed:issue1lld:pubmed
pubmed-article:1709804pubmed:dateCreated1991-6-24lld:pubmed
pubmed-article:1709804pubmed:abstractTextWe report two cases of heparin induced thrombocytopenia (HIT), in patients who required anticoagulation for extracorporeal procedures (haemodialysis and cardiopulmonary bypass) one associated with recurrent thrombosis of the artificial circuits. Resolution of thrombocytopenia and successful anticoagulation were achieved using a low molecular weight heparinoid (LMWH) Org 10172. Anticoagulation was monitored using estimations of plasma anti-factor Xa activity. These cases demonstrate that LMWH provides safe and effective anticoagulation in patients in whom unfractionated heparin has caused HIT.lld:pubmed
pubmed-article:1709804pubmed:languageenglld:pubmed
pubmed-article:1709804pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1709804pubmed:citationSubsetIMlld:pubmed
pubmed-article:1709804pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1709804pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1709804pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1709804pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1709804pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1709804pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1709804pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1709804pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1709804pubmed:statusMEDLINElld:pubmed
pubmed-article:1709804pubmed:monthFeblld:pubmed
pubmed-article:1709804pubmed:issn0004-8291lld:pubmed
pubmed-article:1709804pubmed:authorpubmed-author:EvansSSlld:pubmed
pubmed-article:1709804pubmed:authorpubmed-author:RozenbergM...lld:pubmed
pubmed-article:1709804pubmed:authorpubmed-author:MurrayBBlld:pubmed
pubmed-article:1709804pubmed:authorpubmed-author:RowlingsP APAlld:pubmed
pubmed-article:1709804pubmed:authorpubmed-author:MansbergRRlld:pubmed
pubmed-article:1709804pubmed:issnTypePrintlld:pubmed
pubmed-article:1709804pubmed:volume21lld:pubmed
pubmed-article:1709804pubmed:ownerNLMlld:pubmed
pubmed-article:1709804pubmed:authorsCompleteYlld:pubmed
pubmed-article:1709804pubmed:pagination52-4lld:pubmed
pubmed-article:1709804pubmed:dateRevised2005-5-12lld:pubmed
pubmed-article:1709804pubmed:meshHeadingpubmed-meshheading:1709804-...lld:pubmed
pubmed-article:1709804pubmed:meshHeadingpubmed-meshheading:1709804-...lld:pubmed
pubmed-article:1709804pubmed:meshHeadingpubmed-meshheading:1709804-...lld:pubmed
pubmed-article:1709804pubmed:meshHeadingpubmed-meshheading:1709804-...lld:pubmed
pubmed-article:1709804pubmed:meshHeadingpubmed-meshheading:1709804-...lld:pubmed
pubmed-article:1709804pubmed:meshHeadingpubmed-meshheading:1709804-...lld:pubmed
pubmed-article:1709804pubmed:meshHeadingpubmed-meshheading:1709804-...lld:pubmed
pubmed-article:1709804pubmed:meshHeadingpubmed-meshheading:1709804-...lld:pubmed
pubmed-article:1709804pubmed:meshHeadingpubmed-meshheading:1709804-...lld:pubmed
pubmed-article:1709804pubmed:meshHeadingpubmed-meshheading:1709804-...lld:pubmed
pubmed-article:1709804pubmed:meshHeadingpubmed-meshheading:1709804-...lld:pubmed
pubmed-article:1709804pubmed:meshHeadingpubmed-meshheading:1709804-...lld:pubmed
pubmed-article:1709804pubmed:meshHeadingpubmed-meshheading:1709804-...lld:pubmed
pubmed-article:1709804pubmed:meshHeadingpubmed-meshheading:1709804-...lld:pubmed
pubmed-article:1709804pubmed:year1991lld:pubmed
pubmed-article:1709804pubmed:articleTitleThe use of a low molecular weight heparinoid (Org 10172) for extracorporeal procedures in patients with heparin dependent thrombocytopenia and thrombosis.lld:pubmed
pubmed-article:1709804pubmed:affiliationDepartment of Haematology, Prince Henry Hospital, Sydney, NSW.lld:pubmed
pubmed-article:1709804pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1709804pubmed:publicationTypeCase Reportslld:pubmed